Legislative Assembly for the ACT: 2009 Week 03 Hansard (Tuesday, 24 February 2009) . . Page.. 885 ..
MS GALLAGHER: As required under section 19 of the Territory-owned Corporations Act 1990, I hereby present a 2008-09 statement of corporate intent for Rhodium Asset Solutions. This initial statement reflects Rhodium continuing to trade as normal throughout 2008-09 as it was prepared immediately following the government announcement that the proposed sale of the company would not go ahead.
However, in submitting the statement of corporate intent to the voting shareholders, Rhodium foreshadowed that a revised statement of corporate intent would be provided as more information became available about the decision to wind the company down. You may recall that on 10 February 2009 this Assembly passed a resolution agreeing to dispose of Rhodium’s main undertaking. I therefore expect Rhodium will soon be submitting a revised statement of corporate intent to the voting shareholders.
As soon as the board has finalised Rhodium’s modified statement of corporate intent, it will also be tabled in the Assembly as required under section 21 of the Territory-owned Corporations Act. In the meantime, I commend Rhodium’s initial 2008-09 statement of corporate intent to the Assembly whilst noting that it contains limited financial information.
Ms Gallagher presented the following paper, which was circulated to members when the Assembly was not sitting:
Financial Management Act, pursuant to section 26—Consolidated Financial Report—Financial quarter ending 31 December 2008.
Operations of the Gene Technology Regulator—quarterly report
Paper and statement by minister
MS GALLAGHER (Molonglo—Treasurer, Minister for Health, Minister for Community Services and Minister for Women): For the information of members, I present the following paper:
Gene Technology Act, pursuant to subsection 136A(3)—Operations of the Gene Technology Regulator—Quarterly report—1 July to 30 September 2008, dated 1 December 2008.
I seek leave to make a short statement in relation to the paper.
MS GALLAGHER: I present the 1 July to 30 September 2008 quarterly report of the Gene Technology Regulator. Under section 136A of the Gene Technology Act, the regulator must prepare and give the Minister for Health quarterly reports on the operations of the regulator under the act as soon as practicable after the end of the quarterly reporting period.